Summary
Ubiquinone (UQ) and α-tocopherol (AT) are two highly lipophilic antioxidants which can be dissolved only in lipid layers or attached to protein structures. Analyses of both UQ and AT in whole blood and plasma demonstrate identical values, which excludes any significant allocation to blood cells. The lipoidic plasma structures constitute the plasma lipoprotein fractions of high (HDL), low (LDL), and very low (VLDL) density in addition to chylomicrons. This means by definition that blood and plasma UQ and AT values are limited if not related to the lipoidic deposit volume. UQ and AT increase linearly with free cholesterol (FC). FC has therefore been suggested to be a good marker for the deposit volume. The ratios UQ and AT over FC - normalized UQ (N-UQ) and normalized AT (N-AT) - have been computed for inter-and intraindividual comparisons. With a plasma UQ content of 1 μg/ml (≈ 1 μmol/l) and a plasma volume of 41, UQ makes up about 15% of the total heart content or under 1% of UQ in skeletal muscle. The corresponding value for the total extracellular UQ content is less than 2%. This means that extracellular UQ has no or a very minor role as a UQ depot. The same is true for AT. However, for transportation and allocation determinations of N-UQ and N-AT are relevant. Assuming only a lipoprotein-related transportation, healthy persons have saturated plasma UQ and AT values in only 25% and 10% of the population, respectively. All patient categories studied have been found nonsaturated. VLDL plus LDL constitute some 90% of the UQ deposit volume. VLDL and LDL are released from the liver to transport fat, for example, to muscle tissue. HDL has a corresponding cholesterol-transporting function. Uptake depends on the local lipoprotein lipase activity. Do these transports also function as means for UQ and AT transport? Per unit of FC, UQ content in VLDL+LDL is about five times that in HDL. The corresponding AT value is about unity. This difference between UQ and AT storage does not exclude the possibility that VLDL+LDL particles possess the ability to transport UQ between different compartments when so necessary.
Similar content being viewed by others
Abbreviations
- AT:
-
α-tocopherol
- FC:
-
free cholesterol
- HDL:
-
high-density lipoprotein
- LDL:
-
low-density lipoprotein
- VLDL:
-
very low density lipoprotein
- IHD:
-
ischemic heart disease
- LPL:
-
lipoprotein lipase
- PUFA:
-
polyunsaturated fatty acids
- UQ:
-
ubuiquinone
- N-AT:
-
AT/FC ratio
- N-UQ:
-
UQ/FC ratio
References
Appelkvist E-L, Karlén A, Dallner G (1991) Biosynthesis and regulation of coenzyme Q. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Beyer RE (1991) The role of coenzyme Q in endurance training-acquired resistance to free radical damage. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Bogentoft C, Edlund PO, Olsson B, Widlund L, Westensen K (1991) Biopharmaceutical aspects of intravenous and oral administration of coenzyme Q. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Crane FL (1990) Development of concepts for the role of ubiquinones in biological membranes. In: Lenaz G, Barnabei O, Rabbi A, Battino M (eds) Highlights in ubiquinone research. Taylor and Francis, London
Edlund P-O (1988) Determination of coenzyme Q10 α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 425:87–97
Ernster L, Beyer RE (1991) Antioxidant functions of coenzyme Q: some biochemical and pathophysiological implications. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Esterbauer H, Jürgens G, Quehenberger O, Koller E (1987) Autoxidation of human low density lipoproptein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 28:495–509
Esterbauer H, Waeg G, Puhl H, Dieber-Rotheneder M (1990) Mechanism of oxidation of low density lipoproteins. In: Ingelman-Sundberg M, Gustafsson J-Å, Orrenius S (eds) Drug metabolizing enzymes: genetics, regulation and toxicology. Karolinska Institute, Stockholm
Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G (1991) Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53[Suppl]: 314–321
Folkers K, Langsjoen P, Willis R, Richardson P, Xia L-J, Ye CQ, Tamagawa H (1990) Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA 87:8931–8934
Grey KF (1986) On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 37:53–91
Halliwell B, Gutteridge JMC (1989) Lipid peroxidation: a radical chain reaction. In: Halliwell B, Gutteridge JMC (eds) Free Radicals in Biology and Medicine. Clarendon, Oxford
Horwitt MK, Harvey CC, Dahm CH, Searcy MT (1972) Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. NY Acad Sci 203:223–236
Jameson S (1991) Coenzyme Q10, alpha-tocopherol, and free cholesterol levels in sera from diabetic patients. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Johansen K, Theorell H, Karlsson J, Diamant B, Folkers K (1991) Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. Ann Med 23:649–656
Karlsson J (1979) Localized muscular fatigue: role of muscle metabolism and substrate depletion. In: Hutton RS, Miller DJ (eds) Exercise and sports sciences review. Franklin Institute, Philadelphia
Karlsso, J (1986) Muscle exercise, energy metabolism and blood lactate. In: Tavazzi L, di Prampero PE (eds) The anaerobic threshold. Physiological and clinical significance. Karger, Basel
Karlsson J (1987) Heart and skeletal muscle ubiquinone or CoQ10 as a protective agent against radical formation in man. In: Benzi G (ed) Advances in Myochemistry. Libbey, London
Karlsson J, Folkers K, Åström H, Jansson E, Pernow B, Holmgren A, Mellstedt H, Diamant B (1986) Effect of Adriamycin on heart and skeletal muscle Q in man. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Karlsson J, Diamant B, Folkers K, Edlund PO, Lund B, Theorell H (1990) Plasma ubiquinone and cholesterol contents with and without ubiquinone treatment. In: Lenaz G, Barnabei O, Rabbi A, Battino M (eds) Highlights in ubiquinone research. Taylor and Francis, London
Karlsson J, Diamant B, Folkers K, Edlund PO, Lund B, Theorell H (1990) Skeletal muscle and blood CoQ10 in health and disease. In: Lenaz L, Barnabei O, Rabbi A, Battino M (eds) Highlights in ubiquinone research. Taylor and Francis, London
Karlsson J, Diamant B, Folkers K, Lund B (1991) Muscle fiber types, ubiquinone content and exercise capacity in hypertension and effort angina. Ann Med 23:339–344
Karlsson J, Diamant B, Theorell H, Folkers K (1991) Skeletal muscle coenzyme Q10 in healthy man and selected patient groups. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q, vol VI. Elsevier, Amsterdam
Karlsson J, Diamant B, Theorell H, Johansen K, Folkers K (1992) Plasma alpha-tocopherol and ubiquinone and their relations to muscle function in healthy human and in cardiac diseases. In: Packer L, Fuchs LJ (eds) Vitamin E: biochemistry and clinical applications. Dekker, New York
Karlsson J, Diamant B, Edlund PO, Lund B, Folkers K, Theorell H (1992) Plasma ubiquinone, alpha-tocopherol and cholesterol in man. Int J Vit Nutr Res 62:160–164
Kiessling K-H, Piehl K, Lundquist CG (1970) Number and size of skeletal muscle mitochondria in trained and sedentary men. In: Larsen OA, Malmborg RO (eds) Coronary heart disease and physical fitness. Munksgaard, Copenhagen
Kiessling K-H, Pilström L, Karlsson J, Piehl K (1973) Mitochondrial volume in skeletal muscle from young and old physically untrained and trained healthy men and from alcoholics. Clin Sci 44:547–554
King TE (1990) Preparation, properties and reconstitution of QP-C. In: Lenaz G, Barnabei O, Rabbi A, Battino M (eds) Highlights in ubiquinone research. Taylor and Francis, London
King TE, Xu Y, Wang TY, Ding WH (1986) A mitochondrial coenzyme Q protein - QP-C. In: Folkers K, Yamamura Y (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Lawson DEM, Threfall DR, Glover J, Morton RA (1961) Biosynthesis of ubiquinone in the rat. Biochem J 79:201–208
Lin L, Sotonyi P, Somogyi E, Karlsson J, Folkers K, Nara Y, Sylvén C, Kaijser L, Jansson E (1988) Coenzyme Q10 content in different parts of the normal human heart. Clin Physiol 8:391–398
Nikkila EA, Kuusi T, Taskinen MR (1982) Role of lipoproteinlipase and hepatic endothelial lipase in the metabolism of high density lipoproteins: a novel concept on cholesterol transport in HDL cycle. In: Carlsson A, Pernow B (eds) Metabolis risk factors in ischemic cardiovascular disease. Raven, New York
Okamoto T, Matruya T, Fukunaga Y, Kishio T, Yamagami T (1989) Human serum ubiquinol-10 levels and relationship to serum lipids. Int J Vit Nutr Res 59:288–292
Packer L, Kagan V, Serbinova E (1991) Participation of ubiquinones in membrane antioxidation: direct radical scavenging or tocopherol recycling. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam
Quinn MT, Parthasarathy S, Fong LG, Steinberg D (1987) Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84:2995–2998
Thompson GR (1989) A handbook of hyperlipidemia. Current Science, London
Vadhanavikit S, Morishita M, Duff GA, Folkers K (1984) Microanalyses for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts. Biochem Biophys Res Commun 123:1165–1169
Willis RA, Folkers K, Tucker JL, Xia LJ, Tamagawa H (1990) Lovastatin decreases coenzyme Q levels in rats. Proc Natl Sci USA 87:8928–8930
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karlsson, J., Diamant, B., Theorell, H. et al. Ubiquinone and α-tocopherol in plasma; means of translocation or depot. Clin Investig 71 (Suppl 8), S84–S91 (1993). https://doi.org/10.1007/BF00226846
Issue Date:
DOI: https://doi.org/10.1007/BF00226846